Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03382093 · ClinicalTrials.gov registry record · NA

Personalized Feedback for Smokers With Elevated Anxiety Sensitivity

A NA study of Anxiety and Anxiety Disorders, sponsored by University of Houston.

Completed
Registry status
NA
Development phase
95
Enrollment target
1
Study location

NCT03382093 is a NA study of Anxiety and Anxiety Disorders that has completed, run by University of Houston. The registered enrollment target is 95 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03382093, a NA study of Anxiety and Anxiety Disorders, has completed, sponsored by University of Houston.

COMPLETED
Registry status
NA
Development phase
95 participants
Enrollment target
1
Study location

Study Summary

This project will develop and refine a computer-delivered integrated Personalized Feedback Intervention (PFI) that directly addresses smoking and anxiety sensitivity (AS). The PFI will focus on feedback about smoking behavior, AS, and adaptive coping strategies.

Interventions

  • BEHAVIORAL Personalized Feedback Intervention
  • BEHAVIORAL Smoking Information Control

Study Locations (1)

Texas

  • Anxiety and Health Research Laboratory and Substance Use Treatment Clinic, University of Houston - Houston

Trial Details

FieldValue
Enrollment Target 95 participants
Start Date 2017-08-23
Est. Completion 2019-06-01
Phase NA

Sponsor

University of Houston

64 total trials

What the Registry Record Tells You About NCT03382093

The ClinicalTrials.gov registry entry for NCT03382093 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 95 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (78% lower). The listed sponsor is University of Houston, which has 64 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Anxiety appearing as the primary indexed condition, and to 2 interventions - of which Personalized Feedback Intervention is the first listed.

NCT03382093 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT03382093 about?

NCT03382093 is a clinical study titled "Personalized Feedback for Smokers With Elevated Anxiety Sensitivity". This project will develop and refine a computer-delivered integrated Personalized Feedback Intervention (PFI) that directly addresses smoking and anxiety sensitivity (AS). The PFI will focus on feedback about smoking behavior, AS, and adaptive coping strategies.

What is the current status of trial NCT03382093?

This trial is currently completed. It is a NA study. The enrollment target is 95 participants. The study started on 2017-08-23. Estimated completion is 2019-06-01.

What conditions does trial NCT03382093 study?

This clinical trial studies the following conditions: Anxiety, Anxiety Disorders, Tobacco Dependence, Smoking, Cigarette, Smoking, Tobacco.

What interventions are being tested in trial NCT03382093?

The interventions under investigation include: Personalized Feedback Intervention (BEHAVIORAL), Smoking Information Control (BEHAVIORAL).

Who is sponsoring clinical trial NCT03382093?

This trial is sponsored by University of Houston, which has 64 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03382093 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anxiety

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.